Oxygen injection site affects FIO2 during noninvasive ventilation

Area of Science:

• Respiratory physiology
• Medical device engineering

Background:

• Portable bi-level positive airway pressure (PAP) devices often lack integrated air-oxygen blenders.
• Precise regulation of fraction of inspired oxygen (FIO2) requires supplemental oxygen, but influencing factors are poorly understood.
• Previous studies on FIO2 determinants in noninvasive ventilation (NIV) yielded inconsistent results.

Purpose of the Study:

• To investigate in vitro the effects of NIV parameters on FIO2.
• To specifically evaluate the impact of oxygen injection site on FIO2 delivery.
• To identify optimal configurations for accurate oxygen concentration during NIV.

Main Methods:

• Noninvasive ventilation (NIV) was simulated using a test lung and manikin.
• Fraction of inspired oxygen (FIO2) was measured across four distinct oxygen injection sites.
• Variations in exhalation valve type, oxygen flow rates, and inspiratory/expiratory pressure settings were systematically analyzed.

Main Results:

• Oxygen flow, inspiratory/expiratory pressures, and exhalation valve type all influenced FIO2.
• The oxygen injection site emerged as the most critical factor affecting FIO2 for a given oxygen flow.
• Injecting oxygen at the mask, closest to the patient, yielded significantly higher FIO2 (P < .001).

Conclusions:

• Oxygen injection site is the primary determinant of FIO2 during NIV.
• Mask-level oxygen delivery optimizes FIO2 compared to other tested sites.
• Findings provide crucial data for improving oxygen delivery accuracy in NIV therapy.